Cargando…
Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants
PURPOSE: Despite the growing interest in bacteriophage (phage) usage for the prevention, control, and removal of bacterial biofilms, few scientific data exist on phage applications on medical implant surfaces, while none exists on multiple implants. In this study, we aimed to isolate, biophysically...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166914/ https://www.ncbi.nlm.nih.gov/pubmed/35668859 http://dx.doi.org/10.2147/IDR.S367460 |
_version_ | 1784720714507485184 |
---|---|
author | Amankwah, Stephen Adisu, Mekonen Gorems, Kasahun Abdella, Kedir Kassa, Tesfaye |
author_facet | Amankwah, Stephen Adisu, Mekonen Gorems, Kasahun Abdella, Kedir Kassa, Tesfaye |
author_sort | Amankwah, Stephen |
collection | PubMed |
description | PURPOSE: Despite the growing interest in bacteriophage (phage) usage for the prevention, control, and removal of bacterial biofilms, few scientific data exist on phage applications on medical implant surfaces, while none exists on multiple implants. In this study, we aimed to isolate, biophysically characterize and assess phages as potential antibiofilm agents to inhibit and remove multidrug-resistant (MDR) Pseudomonas aeruginosa biofilm on catheter and endotracheal tube surfaces. METHODS: The well-identified stored clinical isolates (n = 7) of MDR P. aeruginosa were obtained from Jimma Medical Center. Specific phages were isolated and characterized based on standard protocols. The phages were tested for their antibiofilm effects in preventing colonization and removing preformed biofilms of MDR P. aeruginosa, following phage coating and treatment of catheter and endotracheal tube segments. RESULTS: Two P. aeruginosa-specific phages (ΦJHS-PA1139 and ΦSMK-PA1139) were isolated from JMC compound sewage sources. The phages were biophysically characterized as being thermally stable up to 40°C and viable between pH 4.0 and 11.0. The two phages tested against clinical MDR strains of P. aeruginosa showed broad host ranges but not on other tested bacterial species. Both phages reduced MDR bacterial biofilms during the screening step. The phage-coated segments showed 1.2 log(10) up to 3.2 log(10) inhibition relative to non-coated segments following 6 h coating of segments prior to microbial load exposure. In both phages, 6 h treatment of the segments with 10(6) PFU/mL yielded 1.0 log(10) up to 1.6 log(10) reductions for ΦJHS and 1.6 log(10) up to 2.4 log(10) reductions for ΦSMK. CONCLUSION: Our results suggest that phages have great potential to serve the dual purpose as surface coating agents for preventing MDR bacterial colonization in medical implants and as biofilm removal agents in implant-associated infections. |
format | Online Article Text |
id | pubmed-9166914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91669142022-06-05 Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants Amankwah, Stephen Adisu, Mekonen Gorems, Kasahun Abdella, Kedir Kassa, Tesfaye Infect Drug Resist Original Research PURPOSE: Despite the growing interest in bacteriophage (phage) usage for the prevention, control, and removal of bacterial biofilms, few scientific data exist on phage applications on medical implant surfaces, while none exists on multiple implants. In this study, we aimed to isolate, biophysically characterize and assess phages as potential antibiofilm agents to inhibit and remove multidrug-resistant (MDR) Pseudomonas aeruginosa biofilm on catheter and endotracheal tube surfaces. METHODS: The well-identified stored clinical isolates (n = 7) of MDR P. aeruginosa were obtained from Jimma Medical Center. Specific phages were isolated and characterized based on standard protocols. The phages were tested for their antibiofilm effects in preventing colonization and removing preformed biofilms of MDR P. aeruginosa, following phage coating and treatment of catheter and endotracheal tube segments. RESULTS: Two P. aeruginosa-specific phages (ΦJHS-PA1139 and ΦSMK-PA1139) were isolated from JMC compound sewage sources. The phages were biophysically characterized as being thermally stable up to 40°C and viable between pH 4.0 and 11.0. The two phages tested against clinical MDR strains of P. aeruginosa showed broad host ranges but not on other tested bacterial species. Both phages reduced MDR bacterial biofilms during the screening step. The phage-coated segments showed 1.2 log(10) up to 3.2 log(10) inhibition relative to non-coated segments following 6 h coating of segments prior to microbial load exposure. In both phages, 6 h treatment of the segments with 10(6) PFU/mL yielded 1.0 log(10) up to 1.6 log(10) reductions for ΦJHS and 1.6 log(10) up to 2.4 log(10) reductions for ΦSMK. CONCLUSION: Our results suggest that phages have great potential to serve the dual purpose as surface coating agents for preventing MDR bacterial colonization in medical implants and as biofilm removal agents in implant-associated infections. Dove 2022-05-31 /pmc/articles/PMC9166914/ /pubmed/35668859 http://dx.doi.org/10.2147/IDR.S367460 Text en © 2022 Amankwah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Amankwah, Stephen Adisu, Mekonen Gorems, Kasahun Abdella, Kedir Kassa, Tesfaye Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants |
title | Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants |
title_full | Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants |
title_fullStr | Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants |
title_full_unstemmed | Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants |
title_short | Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants |
title_sort | assessment of phage-mediated inhibition and removal of multidrug-resistant pseudomonas aeruginosa biofilm on medical implants |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166914/ https://www.ncbi.nlm.nih.gov/pubmed/35668859 http://dx.doi.org/10.2147/IDR.S367460 |
work_keys_str_mv | AT amankwahstephen assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants AT adisumekonen assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants AT goremskasahun assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants AT abdellakedir assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants AT kassatesfaye assessmentofphagemediatedinhibitionandremovalofmultidrugresistantpseudomonasaeruginosabiofilmonmedicalimplants |